Report Detail
Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019
- RnM3839052 |
- 28 November, 2019 |
- Global |
- 130 Pages |
- GlobalData |
- Medical Devices & Consumables
Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, “Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiac Markers Rapid Tests & Point of Care (POC) currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Markers Rapid Tests & Point of Care (POC) pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Cardiac Markers Rapid Tests & Point of Care (POC) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiac Markers Rapid Tests & Point of Care (POC) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiac Markers Rapid Tests & Point of Care (POC) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
- 1.1 List of Tables 5
- 1.2 List of Figures 9
2 Introduction 10
- 2.1 Cardiac Markers Rapid Tests & Point of Care (POC) Overview 10
3 Products under Development 11
- 3.1 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 11
- 3.2 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Segment 12
- 3.3 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Territory 13
- 3.4 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path 14
- 3.5 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date 15
4 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products under Development by Companies 16
- 4.1 Cardiac Markers Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development 16
- 4.2 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 19
5 Cardiac Markers Rapid Tests & Point of Care (POC) Companies and Product Overview 22
- 5.1 1Drop Diagnostics Company Overview 22
- 5.1.1 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 22
- 5.2 Abbott Point of Care Inc Company Overview 23
- 5.2.1 Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview 23
- 5.3 Accel Diagnostics LLC Company Overview 24
- 5.3.1 Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 24
- 5.4 Akers Biosciences Inc Company Overview 25
- 5.4.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 25
- 5.5 Akrivis Technologies LLC Company Overview 26
- 5.5.1 Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 26
- 5.6 Alfa Wassermann Inc Company Overview 27
- 5.6.1 Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview 27
- 5.7 Angle Biosciences Inc Company Overview 29
- 5.7.1 Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 29
- 5.8 Anteo Diagnostics Ltd Company Overview 30
- 5.8.1 Anteo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
- 5.9 Atonomics A/S Company Overview 31
- 5.9.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 31
- 5.10 Axis-Shield Diagnostics Ltd Company Overview 33
- 5.10.1 Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
- 5.11 BBB Technologies Inc Company Overview 34
- 5.11.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 34
- 5.12 Bio-AMD Inc Company Overview 35
- 5.12.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 35
- 5.13 BioMedomics Inc Company Overview 38
- 5.13.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 38
- 5.14 BiOracle Ltd (Inactive) Company Overview 39
- 5.14.1 BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39
- 5.15 Biosensia Ltd Company Overview 40
- 5.15.1 Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 40
- 5.16 Biostealth, Inc. Company Overview 41
- 5.16.1 Biostealth, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
- 5.17 Biosurfit, SA Company Overview 42
- 5.17.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview 42
- 5.18 Brava Diagnostics Company Overview 43
- 5.18.1 Brava Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 43
- 5.19 Carclo Diagnostic Solutions Ltd Company Overview 44
- 5.19.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
- 5.20 CardioGenics Inc Company Overview 45
- 5.20.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
- 5.21 Cordex Systems, LLC Company Overview 46
- 5.21.1 Cordex Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 46
- 5.22 Coris BioConcept Company Overview 47
- 5.22.1 Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview 47
- 5.23 Critical Diagnostics Company Overview 48
- 5.23.1 Critical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 48
- 5.24 Diazyme Laboratories Inc Company Overview 49
- 5.24.1 Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 49
- 5.25 DSC Technologies Inc Company Overview 50
- 5.25.1 DSC Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 50
- 5.26 Duke University Company Overview 51
- 5.26.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 51
- 5.27 Dynasil Corporation of America Company Overview 53
- 5.27.1 Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview 53
- 5.28 Edan Instruments Inc Company Overview 54
- 5.28.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 54
- 5.29 Epinex Diagnostics Inc Company Overview 57
- 5.29.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 57
- 5.30 ET Healthcare Inc Company Overview 58
- 5.30.1 ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 58
- 5.31 Group K Diagnostics Company Overview 61
- 5.31.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 61
- 5.32 LeukoDx Ltd Company Overview 63
- 5.32.1 LeukoDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 63
- 5.33 MML Ltd Company Overview 64
- 5.33.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 64
- 5.34 Nanomix Inc Company Overview 66
- 5.34.1 Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview 66
- 5.35 Novartis AG Company Overview 68
- 5.35.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 68
- 5.36 Ohmx Corp Company Overview 69
- 5.36.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 69
- 5.37 OPKO Health Inc Company Overview 73
- 5.37.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 73
- 5.38 Prolight Diagnostics AB Company Overview 75
- 5.38.1 Prolight Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 75
- 5.39 QLIDA Diagnostics Company Overview 76
- 5.39.1 QLIDA Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 76
- 5.40 QuickCheck Health Inc Company Overview 77
- 5.40.1 QuickCheck Health Inc Pipeline Products & Ongoing Clinical Trials Overview 77
- 5.41 Quidel Corp Company Overview 78
- 5.41.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 78
- 5.42 Radiometer Medical ApS Company Overview 79
- 5.42.1 Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview 79
- 5.43 Radisens Diagnostics Ltd Company Overview 80
- 5.43.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
- 5.44 Resdin Technologies Inc. Company Overview 81
- 5.44.1 Resdin Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
- 5.45 Sandia National Laboratories Company Overview 82
- 5.45.1 Sandia National Laboratories Pipeline Products & Ongoing Clinical Trials Overview 82
- 5.46 Sarissa-Biomedical Ltd Company Overview 85
- 5.46.1 Sarissa-Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
- 5.47 Selfa, Inc. Company Overview 86
- 5.47.1 Selfa, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
- 5.48 SpinChip Diagnostics AS Company Overview 87
- 5.48.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 87
- 5.49 Thermo Fisher Scientific Inc Company Overview 88
- 5.49.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 88
- 5.50 ThreeFold Sensors (Inactive) Company Overview 89
- 5.50.1 ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 89
- 5.51 Trinity Biotech Plc Company Overview 90
- 5.51.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 90
- 5.52 True Diagnostics Inc Company Overview 93
- 5.52.1 True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 93
- 5.53 Universal Biosensors Inc Company Overview 94
- 5.53.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview 94
- 5.54 University of Vermont Company Overview 95
- 5.54.1 University of Vermont Pipeline Products & Ongoing Clinical Trials Overview 95
- 5.55 Upstream Medical Technologies Ltd Company Overview 96
- 5.55.1 Upstream Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 96
- 5.56 XCellCure, LLC Company Overview 105
- 5.56.1 XCellCure, LLC Pipeline Products & Ongoing Clinical Trials Overview 105
6 Cardiac Markers Rapid Tests & Point of Care (POC) - Recent Developments 108
- 6.1 Oct 23, 2019: bioMerieux – Third-Quarter 2019 Business Review 108
- 6.2 Oct 22, 2019: bioMerieux – Third quarter 2019 business review 109
- 6.3 Oct 16, 2019: Trinity Biotech announces results for Q3, 2019 111
- 6.4 Sep 04, 2019: bioMerieux announces First-Half 2019 Results 112
- 6.5 Aug 20, 2019: Trinity Biotech announces results for Q2, 2019 115
- 6.6 May 07, 2019: Trinity Biotech announces results for Q1, 2019 117
- 6.7 Apr 24, 2019: bioMerieux: First-quarter 2019 business review 119
- 6.8 Mar 07, 2019: Trinity Biotech announces quarter 4 and fiscal year 2018 financial results 120
- 6.9 Feb 27, 2019: bioMerieux – 2018 Financial Results 122
- 6.10 Jan 25, 2019: Introducing DiaSys’ new CEO Dr. Jan Gorka 126
- 6.11 Dec 07, 2018: Quidel comments on California court ruling 126
7 Appendix 127
- 7.1 Methodology 127
- 7.2 About GlobalData 130
- 7.3 Contact Us 130
Summary:
Get latest Market Research Reports on Cardiac Markers Rapid Tests & Point of Care (POC). Industry analysis & Market Report on Cardiac Markers Rapid Tests & Point of Care (POC) is a syndicated market report, published as Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019. It is complete Research Study and Industry Analysis of Cardiac Markers Rapid Tests & Point of Care (POC) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
